This report provides a detailed breakdown of the applications and markets for gene therapy as well as an analysis of future growth trends. The report details the latest developments of pre-clinical and clinical status in gene therapy areas.
Delivery mechanisms in gene therapy such as viral and non-viral delivery systems are described in detail. The FDA regulation of gene therapy is overviewed as well. The report contains company profiles as well as expert opinions from those active in this area.
About the author:
Dr. Anil Sehgal obtained his Ph.D. in Biomedical Sciences in 1994 from a Joint Program between Old Dominion University and Eastern Virginia Medical School. He served as Assistant Member at the Pacific Northwest Cancer Foundation in Seattle before joining UCSF. He initiated a molecular marker program in brain tumor area at UCSF. He has published over 20 publications and presented in over 40 National and International Conferences. He also holds several patents in the area of markers and targets for cancer therapeutics. He recently served as Director of Molecular Biology and Genomics at ChemGenex Therapeutics. He is currently working as a consultant for startup companies.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
